DCR

mGC or mGEJC - L2 - all population metastatic/advanced mGC or mGEJC mGC or mGEJC - 2nd Line (L2) mGC or mGEJC - L2 - all population

versus irinotecan
avelumab alone vs. irinotecan 1 1.0better0.35.0100 %